Nathan T Harvey
Overview
Explore the profile of Nathan T Harvey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee W, Barbosa A, Lee A, Currie A, Martino D, Stenos J, et al.
Int J Mol Sci
. 2025 Feb;
26(4).
PMID: 40003986
Tick bites and tick-related diseases are on the rise. Diagnostic tests that identify well-characterised tick-borne pathogens (TBPs) possess limited capacity to address the causation of symptoms associated with poorly characterised...
2.
Knittel R, Harvey N, Mesbah Ardakani N, OBrien B, Lee S, Wood B
Am J Dermatopathol
. 2025 Feb;
PMID: 39912627
Preferentially Expressed Antigen in Melanoma (PRAME) immunohistochemistry has been found to be relatively sensitive and specific for the diagnosis of melanoma, although the detection of PRAME positivity in some melanocytic...
3.
Lee W, Ben-Othman R, Skut P, Lee A, Barbosa A, Beaman M, et al.
Heliyon
. 2024 Jul;
10(13):e33600.
PMID: 39071681
Tick-associated diseases present challenges due to tridirectional interactions among host-specific responses, tick toxins and salivary proteins as well as microbes. We aimed to uncover molecular mechanisms in tick-bitten skin samples...
4.
Yap M, Harvey N, Mesbah Ardakani N, Wood B
Pathology
. 2024 Jun;
56(6):913-915.
PMID: 38834438
No abstract available.
5.
Harvey N, Palmer D, Tucker P, Chakera A, Foster R, Lim W, et al.
JAAD Int
. 2024 Feb;
15:51-58.
PMID: 38371661
Background: Cutaneous squamous cell carcinoma is a significant cause of morbidity for immunosuppressed patients such as organ transplant recipients; however, histological parameters which predict the likelihood of tumor progression are...
6.
Wood B, Harvey N, Mesbah Ardakani N, Paton D
Pathology
. 2024 Feb;
56(3):322-324.
PMID: 38360444
The terms 'Bowen disease' and 'intraepidermal squamous cell carcinoma' are sometimes considered synonymous. In this paper we present historical, clinical, histological and molecular evidence that this is incorrect. The term...
7.
Van Winden V, Wong D, Wood B, Filion P, Harvey N
Pathology
. 2023 Nov;
56(1):47-51.
PMID: 37989630
Morphological overlap exists between cutaneous granular cell tumours (GCT) and malignant melanoma, with the melanocyte-specific markers HMB45 and Melan-A commonly used to support the diagnosis of melanoma. We recently encountered...
8.
Iacobelli J, Harvey N, Mesbah Ardakani N, Ng L, Preston H, Wood B
Am J Dermatopathol
. 2023 Nov;
46(2):98-100.
PMID: 37982500
The distinction between digital papillary adenocarcinoma (DPAC) and benign cutaneous adnexal tumors is clinically important and can be challenging. Poroid hidradenoma frequently occurs at acral sites and can show a...
9.
Bui J, Harvey N, Berry B, Chan J, Ramachandran S, Gough H, et al.
Am J Dermatopathol
. 2022 Aug;
44(10):728-733.
PMID: 35925552
The aim of this study was to review the dermatopathological findings in skin biopsy specimens from pediatric oncology and hematopoietic stem cell transplantation patients over a 20-year period. Three hundred...
10.
Ireland A, Wood B, Whitfield J, Amanuel B, Harvey N, Mesbah Ardakani N
Am J Dermatopathol
. 2022 Apr;
44(8):607-610.
PMID: 35385855
Deep penetrating nevus (DPN) is a pigmented melanocytic tumor which typically displays a wedge-shaped deep penetrating architecture. Some cases show a coexisting component resembling conventional melanocytic nevus. These morphological attributes...